Both hypermethylation of the CIITA promoter IV [65] and/or modification of chromatin structure by histone deacetylation may result in defective CIITA expression in tumor cells, causing a loss of INF-gamma-inducible HLA-DR expression [64]. Here, CIITA is linked to neoplasm.